Pan Pacific Lymphoma Conference

Info   Agenda   Symposiums   Abstracts   Travel   Support   Register

Pan Pacific Lymphoma Conference

Join us in-person or via webstream July 18-22 in Koloa, Hawaii

More than 25 Years of Educational Excellence

The Pan Pacific Lymphoma Conference is one of the largest gatherings of clinicians and researchers specializing in the areas of lymphoma and transplantation. The 2022 event is your chance to explore vital information on clinical updates and research, meet key thought leaders, and exchange ideas with more than 500 members of the multidisciplinary lymphoma clinical team including oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists.

Download Brochure


Conference Objectives

At the conclusion of the conference, the attendee should be better able to:

  1. Discuss common strategies and treatments in the management of lymphoma involving infectious disease prophylaxis, situations for consideration of therapy dose reductions, transfusion pharmacotherapeutics, orphan drugs, and fertility preservation
  2. Identify factors related to provider burnout and the impact of its circumstances on patients' and providers’ well-being
  3. Describe the molecular insights of lymphomagenesis and the pathological pathway to diagnosis of difficult cases
  4. Discuss how minimal residual disease and imaging technologies can be incorporated to assist in improving treatment response evaluations
  5. Assess novel and future therapies for the initial treatment of classical Hodgkin lymphoma (cHL), follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), primary central nervous system (CNS) lymphoma, and peripheral T-cell lymphomas (PTCL)
  6. Evaluate the diverse landscape of monoclonal gammopathies of significance and the intersection of plasma cell dyscrasias
  7. Analyze clinical trial results concerning prognosis and transplant-eligibility criteria for patients with relapsed cHL, FL, marginal zone lymphoma (MZL), and primary refractory DLBCL
  8. Differentiate approaches to treatment for relapsed DLBCL between the need for autologous transplantation versus CAR-T therapy
  9. Explain the roles of the interprofessional health care team in the diagnosis, treatment, management, and support of lymphoma and hematologic malignancies

Conference Venue

Grand Hyatt Kauai Resort & Spa

1571 Poipu Road
Koloa, HI 96756

Telephone: 1-808-742-1234

Grand Hyatt Kauai Resort & Spa 

 

Unable to travel to Hawaii? No worries!

Join the live conference webstream and receive the same number of credits as if you attended the conference in person. The live webstream enables you to participate in this conference from anywhere in the world as long as you have an internet connection.

 

PPLC22 Conference App

We are working on a conference app to help you get the most out of your conference experience right from your mobile phone or tablet! The app will be available to all registered participants so you can:


Conference Directors

James O. Armitage, MD James O. Armitage, MD
Joe Shapiro Professor of Medicine
Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
Matthew A. Lunning, DO, FACP Matthew A. Lunning, DO, FACP
Associate Professor
Division of Oncology and Hematology
Department of Internal Medicine
Assistant Vice Chancellor for Clinical Research
University of Nebraska Medical Center
Julie M. Vose, MD, MBA Julie M. Vose, MD, MBA
Neumann M. and Mildred E. Harris Professor and Chief
Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
   

Accreditation

JA Provider MarkIn support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The University of Nebraska Medical Center designates this live activity for a maximum of 28 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

The University of Nebraska Medical Center designates this activity for up to 28 ANCC contact hours. Nurses should only claim credit for the actual time spent in the activity.

Pharmacists

ACPE logoThe University of Nebraska Medical Center designates this activity for 28 ACPE contact hours. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 30 days after the activity completion. UAN # JA0000319-0000-21-004-L01-P

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

28 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

28 MOC points in the American Board of Pathology's (ABPATH) Maintenance of Certification (MOC) program.

It is the CME Provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.


For More Information

Contact Brenda Ram, CMP, CHCP via email or call 402-559-9250.